HUDSON, N.Y., Aug. 23, 2017 -- Taconic Biosciences announces plans to move its corporate headquarters up the Hudson River from Hudson to the Albany, NY area at the end of 2017. The new location is near several existing Taconic facilities in Rensselaer, 45 miles from its primary operations facility in Germantown, NY, and accessible to all global locations.
With Taconic’s increasing prominence within the global pharmaceutical industry, the location of the new headquarters will provide a more convenient venue for key stakeholders and customers, provide access to highly-skilled talent, and puts Taconic in the center of the booming Albany technology hub. The new facility will house the company’s leadership team, as well as members of its product strategy, marketing, human resources, finance, quality, customer service, and business technology teams. 35 jobs will relocate to the Albany area, while 28 will move to the Germantown facility. “Relocating Taconic’s headquarters to the Health Sciences Campus expands on a long-standing relationship between the two organizations. The resulting co-location of more than 130 Taconic employees will increase internal collaboration across functions. The site’s easily accessible location to highly educated talent, as well as proximity to prospective partners and customers, makes it an ideal fit,” shared David Lester, senior vice president of human resources and organization development.
Located on the Albany Health Sciences Campus in Rensselaer, NY, the new corporate headquarters will be in the state-of-the-art Cancer Research Center building, which already houses Taconic’s molecular analysis laboratory. The site is home to other key players within the pharmaceutical industry, notably Regeneron, Albany Molecular Research, Inc., Albany Medical College, Albany College of Pharmacy, and several other biomedical organizations. Taconic also occupies two other buildings on the campus, housing its scientific services business and operations functions. “We are pleased to expand our relationship with Taconic and bring additional jobs to the UABDC property,” expressed Richard P. McGinn Jr, executive director at the University at Albany Bioscience Development Corporation.
The address of the Cancer Research Center building on the Albany Health Campus is:
1 Discovery Drive
Rensselaer, NY 12144
With over six decades of animal model experience, Taconic Biosciences leveraged its strong roots in the Hudson Valley to build an international organization that is recognized as a global leader in in biomedical research.
To learn more about Taconic Biosciences, please call 1-888-TACONIC (888-822-6642) in the US, or +45 70 23 04 05 in Europe, or email [email protected].
About Taconic Biosciences, Inc.
Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic helps biotechnology companies and institutions acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.
Media Contact: Kelly Owen Grover Director of Marketing Communications (518) 697-3824


China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Bill Ackman Eyes New Fund to Bet Against Market Complacency
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home 



